25 February, 2026 | Online
17:00-18:00 CET
Chairs: Dr Anna Maria Hoffmann-Vold (Oslo, Norway), Prof. Katerina Antoniou (Heraklion, Greece)
Speakers: Prof. Dr Oliver Distler (Zurich, Switzerland), Prof. Dr Elisabetta Renzoni (London, United Kingdom), Dr Jens Vikse (Stavanger, Norway)
Fees: Free for ERS members / €10 for non-members
Find out more about becoming a member
Please note: non-members will need to create a free myERS account to register for this activity.
Treatment of connective tissue disease-associated interstitial lung disease (CTD-ILD) is rapidly evolving and the new guideline provides critical, graded recommendations on pharmacologic and non-pharmacologic management. This webinar addresses an urgent need to educate clinicians on the new treatment algorithm, the use of immunosuppressants and antifibrotics, and the importance of shared decision-making, including the patient's perspective.
One-hour webinar structured as follows:
Following this webinar, participants will be able to:
An application for accreditation of this webinar has been made to the European Board for Accreditation in Pneumology (EBAP) for 1 CME credit per 1-hour attendance. If accredited, the CME credit will be granted upon attendance of at least 60 minutes during the live webinar only.
A webinar closely simulates a lecture-based teaching experience. The speaker can interact with the audience, just as in a classroom setting. During the webinar, you will be asked to share your opinion on issues related to the topic using interactive polls.
All participants will be able to hear the lecturer and see the slides throughout the presentation. As a participant you will be able to pose questions or discuss ideas with the other participants via the text chat facility and the speaker will respond to the questions via the microphone.
More information will be communicated in due course.